XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Redeemable Noncontrolling Interest
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance, beginning of period at Dec. 26, 2021   $ 15.2        
Redeemable Noncontrolling Interest            
Net loss   0.3        
Balance, end of period at Sep. 25, 2022   7.8        
Balance, beginning of period (in shares) at Dec. 26, 2021     124,000,000.0      
Balance, beginning of period at Dec. 26, 2021 $ 945.1   $ 0.0 $ 1,578.9 $ 0.6 $ (634.4)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 19.9     19.9    
Issuance of common stock for employee stock purchase plan and stock options (in shares)     400,000      
Issuance of common stock for employee stock purchase plan and stock options 6.1     6.1    
Restricted stock issued and related taxes (in shares)     1,000,000.0      
Restricted stock issued and related taxes (12.3)     (12.3)    
Issuance of common stock for acquisitions (in shares)     300,000      
Issuance of common stock for acquisitions 5.0     5.0    
Gain on interest rate swap contract 0.0          
Net income (loss) (28.6)         (28.6)
Other comprehensive income (loss), net of tax (4.3)       (4.3)  
Changes in noncontrolling interest (in shares)     200,000      
Changes in noncontrolling interest 4.5 (7.7)   4.5    
Balance, end of period (in shares) at Sep. 25, 2022     125,900,000      
Balance, end of period at Sep. 25, 2022 935.4   $ 0.0 1,602.1 (3.7) (663.0)
Balance, beginning of period at Jun. 26, 2022   7.8        
Balance, end of period at Sep. 25, 2022   7.8        
Balance, beginning of period (in shares) at Jun. 26, 2022     125,600,000      
Balance, beginning of period at Jun. 26, 2022 938.1   $ 0.0 1,593.1 0.0 (655.0)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 6.6     6.6    
Issuance of common stock for employee stock purchase plan and stock options (in shares)     300,000      
Issuance of common stock for employee stock purchase plan and stock options 3.2     3.2    
Restricted stock issued and related taxes (0.8)     (0.8)    
Gain on interest rate swap contract 0.0          
Net income (loss) (8.0)         (8.0)
Other comprehensive income (loss), net of tax (3.7)       (3.7)  
Balance, end of period (in shares) at Sep. 25, 2022     125,900,000      
Balance, end of period at Sep. 25, 2022 $ 935.4   $ 0.0 1,602.1 (3.7) (663.0)
Balance, beginning of period at Dec. 25, 2022   11.2        
Redeemable Noncontrolling Interest            
Net loss   8.1        
Balance, end of period at Oct. 01, 2023   19.3        
Balance, beginning of period (in shares) at Dec. 25, 2022 125,985,306   126,000,000.0      
Balance, beginning of period at Dec. 25, 2022 $ 936.3   $ 0.0 1,608.4 (0.8) (671.3)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 19.0     19.0    
Issuance of common stock for employee stock purchase plan and stock options (in shares)     800,000      
Issuance of common stock for employee stock purchase plan and stock options 6.5     6.5    
Restricted stock issued and related taxes (in shares)     500,000      
Restricted stock issued and related taxes (3.6)     (3.6)    
Gain on interest rate swap contract 3.2       3.2  
Net income (loss) (11.3)         (11.3)
Other comprehensive income (loss), net of tax 0.1       0.1  
Changes in noncontrolling interest (in shares)     800,000      
Changes in noncontrolling interest $ 3.2     3.2    
Balance, end of period (in shares) at Oct. 01, 2023 128,072,596   128,100,000      
Balance, end of period at Oct. 01, 2023 $ 953.4   $ 0.0 1,633.5 2.5 (682.6)
Balance, beginning of period at Jun. 25, 2023   14.7        
Redeemable Noncontrolling Interest            
Net loss   4.6        
Balance, end of period at Oct. 01, 2023   $ 19.3        
Balance, beginning of period (in shares) at Jun. 25, 2023     127,600,000      
Balance, beginning of period at Jun. 25, 2023 945.6   $ 0.0 1,623.7 2.9 (681.0)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 6.4     6.4    
Issuance of common stock for employee stock purchase plan and stock options (in shares)     500,000      
Issuance of common stock for employee stock purchase plan and stock options 3.6     3.6    
Restricted stock issued and related taxes (0.2)     (0.2)    
Gain on interest rate swap contract 1.4       1.4  
Net income (loss) (1.6)         (1.6)
Other comprehensive income (loss), net of tax $ (1.8)       (1.8)  
Balance, end of period (in shares) at Oct. 01, 2023 128,072,596   128,100,000      
Balance, end of period at Oct. 01, 2023 $ 953.4   $ 0.0 $ 1,633.5 $ 2.5 $ (682.6)